Finvest
ADUS Healthcare services · Home care · Medicaid · Acquirer · Thesis updated July 19, 2026

Rate relief is reviving Addus

01 Running thesis

Personal care is healing

Addus looks better after Q1 2026. The two biggest positives are simple. Illinois, its largest market, returned to positive census growth, meaning starts of care were higher than discharges. The Illinois rate increase also began to help margins, with Personal Care G&A at 8.9% of revenue.

The next major swing factor is the CMS 80/20 rule. That rule would have required a large share of some Medicaid payments to go to caregiver pay. Management said recent communications point to this part of the rule being eliminated this year. Outside sources also point to rollback activity, but investors still need official confirmation.

The growth story is not only Illinois. Addus is moving into Indiana through two announced deals, and the Gentiva deal added scale in Texas. This matters because Illinois was 32.1% of Q1 2026 revenue, still large, but down from 37.0% for full-year 2025.

The bear case has not gone away. Addus depends on Medicare and Medicaid funding, so federal policy can hit state budgets. Home Health is also not fixed yet, with Q1 organic revenue down 6.6%, and Hospice margins were weaker year over year.

May 2026▲Q1 2026 strengthened the bull case. Illinois returned to positive census growth, the rate increase helped Personal Care margins, and management said it expects the CMS 80/20 provision to be eliminated this year.
Mar 2026→The 2025 10-K/A was only an administrative amendment. It did not add new financial data or change the thesis.
Feb 2026▼The 2025 10-K confirmed strong revenue growth and lower Illinois concentration, but also showed higher Personal Care G&A and added policy risk from OBBBA.
Nov 2025▼Q3 2025 showed that acquisitions were reducing Illinois concentration, but also lowering Personal Care revenue per billable hour and pressuring margins.
Aug 2025▲Q2 2025 added clear rate catalysts in Illinois and Texas. Those future increases helped offset the known margin drag from Gentiva.
May 2025→Q1 2025 shifted the story from deal approval to execution. Gentiva boosted Personal Care revenue and added Texas exposure, while regulatory uncertainty rose.
Feb 2025▲The 2024 10-K confirmed the Gentiva acquisition and the Illinois rate increase to $29.63 per hour. The key risk moved from approval to integration.
02 Business model

Paid by public programs

Addus sends caregivers, nurses, therapists, and hospice teams into patients' homes. Most patients are older, disabled, or medically fragile. Many are dual eligible, which means they qualify for both Medicare and Medicaid.

The company gets paid by state agencies, federal programs, managed care organizations, insurers, and private customers. Personal Care is usually billed by the hour. Hospice is usually paid by the day. Home Health is mostly paid under Medicare rules for short episodes of skilled care.

This model can be steady because demand for home care grows as the population ages. It can also break when reimbursement rates fail to keep up with wages, or when state budgets tighten. Addus tries to reduce that risk by buying providers in more states and building local scale.

03 Product portfolio

Care at home

Growth engine

Personal Care

This is the main business. Caregivers help with daily needs like bathing, grooming, meals, housekeeping, and other non-medical support.

Steady

Facility staffing

This sits inside Personal Care and supplies staff to places like nursing homes. It can add revenue, but it is not the main thesis driver.

Steady

Hospice

Hospice serves patients with a life expectancy of six months or less. The goal is comfort and quality of life, and Addus is paid mainly through daily rates.

Option

Home Health nursing

This provides skilled nursing after illness or injury. It is a smaller segment and remains under pressure after a Q1 2026 organic revenue decline.

Option

Home Health therapy

Therapy helps patients recover strength and function at home. It could help Addus offer a fuller care model, but the segment needs better volume growth.

04 Business segments

Q1 2026 revenue mix

Personal Care77%modest
Hospice18%flat
Home Health5%declining

Segment shares are from the three months ended March 31, 2026. Illinois remained a major concentration at 32.1% of total net service revenue, while the Illinois Department on Aging was 17.8%.

05 Risk factors

What could go wrong

Medicaid funding squeeze

High impact · Medium odds

Addus is highly tied to Medicaid-funded care. The OBBBA is expected to reduce federal Medicaid spending and change financing mechanics, which could pressure state budgets. If states slow rate increases or cut programs, Addus may have less room to cover wages and overhead.

We watchState Medicaid budgets, waiver funding, and reimbursement rates in Illinois, Texas, and New Mexico.

80/20 rule not fully removed

High impact · Low odds

Management expects the CMS 80/20 Medicaid access provision to be eliminated this year. That would remove a major long-term margin overhang. The risk is that the final rule takes longer, changes shape, or leaves state-level wage pass-through rules in place.

We watchOfficial CMS rulemaking and any final notice covering the Medicaid access provision.

Illinois concentration

Medium impact · Medium odds

Illinois was 32.1% of Q1 2026 revenue, so one state still matters a lot. The Illinois Department on Aging alone was 17.8% of revenue. Diversification is improving, but a local policy or payment issue would still show up quickly.

We watchIllinois revenue share, Illinois Department on Aging share, and Illinois starts of care versus discharges.

Acquisition integration drag

Medium impact · Medium odds

Addus uses acquisitions to enter and deepen markets. Gentiva expanded the Personal Care base, and Indiana adds a new state. The risk is that lower-rate acquired businesses, system conversions, or local execution problems hold back margins.

We watchPersonal Care revenue per billable hour, G&A as a percentage of revenue, and progress closing the second Indiana deal.

Caregiver supply tightens again

Medium impact · Medium odds

Addus can only bill hours when it has caregivers available. Management has pointed to normalized wage inflation near 3% and better candidate flow, but a tighter labor market would hurt fill rates. The caregiver app may help, but it does not remove labor risk.

We watchWage inflation, candidate flow, fill rates on authorized hours, and billable hour growth.

Small segments stay weak

Medium impact · Medium odds

Home Health was only 4.6% of Q1 2026 revenue, but it is shrinking organically. Hospice was larger at 18.1% of revenue, yet its gross margin compressed year over year. Weakness outside Personal Care would make the whole business less balanced.

We watchHome Health organic revenue growth, Home Health volume trends, and Hospice gross margin.
06 Quick answers

In one breath

What does Addus HomeCare do?

Addus provides care in patients' homes. Its largest service is non-medical personal care, with smaller hospice and home health businesses.

Why does Illinois matter so much for ADUS?

Illinois was 32.1% of Q1 2026 revenue, and the Illinois Department on Aging was 17.8%. That makes Illinois rates, budgets, and patient census key drivers of results.

What is the CMS 80/20 rule risk?

The rule would have required a large share of some Medicaid home care payments to go to worker compensation. Addus management expects this provision to be eliminated, but investors should wait for final CMS confirmation.

Is Addus mainly a growth company or a steady care provider?

It is a mix. Demand for home care is steady, but Addus also grows by buying local providers and adding scale in states like Texas, Indiana, and Illinois.